Literature DB >> 11980737

Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?

A J Vincent1, J Zhang, A Ostör, P A W Rogers, B Affandi, G Kovacs, L A Salamonsen.   

Abstract

BACKGROUND: Abnormal uterine bleeding is commonly associated with progestin-only contraceptives, including depot medroxyprogesterone acetate (DMPA), and remains the main reason why these agents are discontinued. Matrix metalloproteinases (MMP), enzymes which degrade specific extracellular matrix components, and leukocytes are implicated in menstruation. Alteration in endometrial MMP-9 and leukocytes has been described in users of other progestin-only contraceptives, suggesting a potential role in the pathogenesis of abnormal uterine bleeding.
METHODS: This study describes the immunohistochemical localization of MMP-9, the tissue inhibitors of metalloproteinases (TIMP)-1, TIMP-2 and TIMP-3, and leukocytes [CD3+ T lymphocytes, CD68+ macrophages and CD56+ uterine natural killer cells (uNK cells)] in the endometrium of women using DMPA. Comparison is made with perimenstrual endometria from normal cycling women.
RESULTS: Similar to the perimenstrual period, an influx of MMP-9 positive cells (identified as neutrophils and CD3+ T cells on the basis of dual immunofluorescence), macrophages and uNK cells was observed in the endometrium of DMPA users. However, significantly more endometrial T lymphocytes were observed in DMPA users. Immunoreactive TIMP, present in all endometrial compartments, demonstrated a significantly decreased immunostaining intensity score in endometrial epithelium (TIMP-1 and TIMP-2), stroma (TIMP-1, TIMP-2 and TIMP-3), endothelium (TIMP-1 and TIMP-2) and vascular smooth muscle (TIMP-1) of DMPA users compared with controls. No correlation was observed between the parameters studied and bleeding patterns reported by subjects.
CONCLUSIONS: These findings provide additional evidence for the importance of the MMP/TIMP balance in the loss/maintenance of endometrial integrity and in the complex pathological mechanisms involved in the troubling side-effect of menstrual bleeding disturbance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11980737     DOI: 10.1093/humrep/17.5.1189

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Regulation of uterine matrix metalloproteinase-9 and the role of microRNAs.

Authors:  Warren B Nothnick
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

2.  Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding.

Authors:  Jacqueline F Donoghue; C Jay McGavigan; Fiona L Lederman; Leonie M Cann; Lulu Fu; Eva Dimitriadis; Jane E Girling; Peter A W Rogers
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

3.  Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding.

Authors:  Ozlem Guzeloglu Kayisli; Umit A Kayisli; Murat Basar; Nihan Semerci; Frederick Schatz; Charles J Lockwood
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

4.  Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.

Authors:  Catherine Bellance; Junaid A Khan; Geri Meduri; Anne Guiochon-Mantel; Marc Lombès; Hugues Loosfelt
Journal:  Mol Biol Cell       Date:  2013-03-13       Impact factor: 4.138

Review 5.  An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract.

Authors:  Hossaena Ayele; Michelle Perner; Lyle R McKinnon; Kenzie Birse; Christina Farr Zuend; Adam Burgener
Journal:  Am J Reprod Immunol       Date:  2021-06-12       Impact factor: 3.886

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.